Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Behandlingsniveau og behandlingsstop ved benign lungesygdom

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{58899442281a4c1cb1ab7dc6ef4a8f2a,
title = "Behandlingsniveau og behandlingsstop ved benign lungesygdom",
abstract = "The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.",
author = "S{\o}rensen, {Anita Rath} and Elisabeth Bendstrup and Anders L{\o}kke and Titlestad, {Ingrid Louise} and Jensen, {Jens Ulrik} and Laura Thomsen and Nassim Roberts and Pia Gj{\o}rup and Saher Shaker and Svend Gundestrup and Torgny Wilcke and Weinreich, {Ulla M{\o}ller} and Kristoffer Marsaa",
year = "2018",
month = "9",
day = "24",
language = "Dansk",
volume = "180",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "39",

}

RIS

TY - JOUR

T1 - Behandlingsniveau og behandlingsstop ved benign lungesygdom

AU - Sørensen, Anita Rath

AU - Bendstrup, Elisabeth

AU - Løkke, Anders

AU - Titlestad, Ingrid Louise

AU - Jensen, Jens Ulrik

AU - Thomsen, Laura

AU - Roberts, Nassim

AU - Gjørup, Pia

AU - Shaker, Saher

AU - Gundestrup, Svend

AU - Wilcke, Torgny

AU - Weinreich, Ulla Møller

AU - Marsaa, Kristoffer

PY - 2018/9/24

Y1 - 2018/9/24

N2 - The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.

AB - The decision to limit or discontinue treatment is a difficult issue, which all physicians will face. Timely communication with information on treatment possibilities and limitations, respectful listening to patients' and informal caregivers' wishes and early palliation is recommended in a stable phase. In some situations, it is better to stop life-prolonging treatment and optimise quality of life in patients with benign pulmonary diseases. Decision on treatment limitations or discontinuation is best taken at a conference and should be based on the patient's wishes, the disease stage and progression and potential reversible components.

M3 - Tidsskriftartikel

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 39

ER -

ID: 56582120